KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) Equity Average (2016 - 2025)

Historic Equity Average for Repligen (RGEN) over the last 15 years, with Q3 2025 value amounting to $2.1 billion.

  • Repligen's Equity Average rose 359.16% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 359.16%. This contributed to the annual value of $2.0 billion for FY2024, which is 160.02% up from last year.
  • Latest data reveals that Repligen reported Equity Average of $2.1 billion as of Q3 2025, which was up 359.16% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Repligen's Equity Average peaked at $2.1 billion during Q3 2025, and registered a low of $1.5 billion during Q1 2021.
  • Over the past 5 years, Repligen's median Equity Average value was $1.9 billion (recorded in 2023), while the average stood at $1.9 billion.
  • In the last 5 years, Repligen's Equity Average soared by 4914.55% in 2021 and then surged by 70.64% in 2025.
  • Repligen's Equity Average (Quarter) stood at $1.7 billion in 2021, then rose by 8.09% to $1.9 billion in 2022, then rose by 5.15% to $2.0 billion in 2023, then grew by 1.29% to $2.0 billion in 2024, then grew by 3.9% to $2.1 billion in 2025.
  • Its Equity Average stands at $2.1 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $2.0 billion for Q1 2025.